Laserfiche WebLink
DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Award <br />Office of the Secretary <br />Award# 1 CPIMP211286-01-00 <br />FAIN# CPIMP211286 <br />Federal Award Date: 06/18/2021 <br />1) Administrative proceeding means a non -judicial process that is adjudicatory in <br />nature in order to make a determination of fault or liability (e.g., Securities and <br />Exchange Commission Administrative proceedings, Civilian Board of Contract <br />Appeals proceedings, and Armed Services Board of Contract Appeals proceedings). <br />This includes proceedings at the Federal and State level but only in connection with <br />performance of a Federal contract or grant. It does not include audits, site visits, <br />corrective plans, or inspection of deliverables. <br />2) Conviction, for purposes of this award term and condition, means a judgment or <br />conviction of a criminal offense by any court of competent jurisdiction, whether <br />entered upon a verdict or a plea, and includes a conviction entered upon a plea of nolo <br />contendere. <br />3) Total value of currently active grants, cooperative agreements, and procurement <br />contracts includes — <br />a) Only the Federal share of the funding under any Federal award with a <br />recipient cost share or match; and <br />b) The value of all expected funding increments under a Federal award and <br />options, even if not yet exercised. <br />F. Disclosure Requirements. <br />Consistent with 45 C.F.R. § 75.113, applicants and recipients must disclose, in a timely manner, in <br />writing to the HHS Awarding Agency, with a copy to the HHS Office of the Inspector General, all <br />information related to violations of Federal criminal law involving fraud, bribery, or gratuity <br />violations potentially affecting the Federal award. Subrecipients must disclose, in a timely manner, in <br />writing to the prime recipient (pass through entity) and the HHS Office of the Inspector General all <br />information related to violations of Federal criminal law involving fraud, bribery, or gratuity <br />violations potentially affecting the Federal award. Disclosures must be sent in writing to the awarding <br />agency and to the HHS OIG at the following addresses: <br />HHS OASH Grants and Acquisitions Management <br />1101 Wootton Parkway, Plaza Level <br />Rockville, MD 20852 <br />FJOI <br />US Department of Health and Human Services Office of Inspector General <br />ATTN: OIG HOTLINE OPERATIONS —MANDATORY GRANT DISCLOSURES <br />PO Box 23489 <br />Washington, DC 20026 <br />URL: htto://oig.hhs.goy/fraud/report-fraud/index.aso <br />(Include "Mandatory Grant Disclosures" in subject line) <br />Fax: 1-800-223-8164 (Include "Mandatory Grant Disclosures" in subject line) <br />Failure to make required disclosures can result in any of the remedies described in 45 C.F.R. § 75.371 <br />("Remedies for noncompliance"), including suspension or debarment (See also 2 C.F.R. Parts 180 & <br />376 and 31 U.S.C. § 3321). <br />City Council <br />8-17 <br />7/20/2021 <br />Page 14 <br />